β¨ Medicines Notices
NEW ZEALAND GAZETTE, No. 25 β 9 MARCH 2017
Tofacitinib
Velpatasvir
Vorapaxar
Schedule 3
Pharmacy-only Medicines
Bifonazole; for dermal use; except for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board
Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams and not more than 50 grams; in slow-release forms containing 665 milligrams or less and more than 500 milligrams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack
Medicines for General Sale
Please note that the following medicines are now available for general sale.
Albutrepenonacog alfa
Bifonazole; for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board
Deoxycholic acid; for oral use
Rurioctocog alfa pegol
Dated this 6th day of March 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health.
2017-go1101
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Alirocumab
Dosage Form:
75mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Product:
Eliriduc
Product:
Active Ingredient:
Alirocumab
Dosage Form:
150mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Product:
Golyra
Product:
Active Ingredient:
Alirocumab
Dosage Form:
75mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Product:
Golyra
Product:
Active Ingredient:
Alirocumab
Dosage Form:
150mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
68
Next Page →
β¨ LLM interpretation of page content
π₯
Classification of Medicines
(continued from previous page)
π₯ Health & Social Welfare6 March 2017
Medicines Classification, Prescription Medicines, Pharmacy-Only Medicines, General Sale Medicines, Medsafe, Ministry of Health
- CHRIS JAMES, Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareNew Medicines, Distribution, Alirocumab, Sanofi-Aventis
NZ Gazette 2017, No 25